Increased levels of Muellerian-inhibiting substance could mean greater breast cancer risk

Oct 09, 2009

Women with increased levels of Müllerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new study published online October 9 in the .

To determine whether MIS levels were associated with breast cancer risk, Joanne F. Dorgan, Ph.D., MPH, of the Fox Chase Cancer Center in Philadelphia, and colleagues conducted a prospective case-control study of 309 participants who were registered in the Columbia, Missouri Bank. Blood samples were donated by women with in situ or who, at the time of donation, were free of cancer. Each of 105 breast cancer patients was matched to two control subjects. MIS was measured in serum using an enzyme-linked immunosorbent assay.

Researchers found that increasing MIS serum concentrations were associated with increased breast cancer risk in this population.

"Additional research is needed, including confirmatory epidemiological studies on the association of serum MIS with and studies aimed at identifying the biological mechanism underlying the association," the authors write.

Source: (news : web)

Explore further: DNA blood test detects lung cancer mutations

Related Stories

Estrogen therapy increases benign breast disease risk

Apr 08, 2008

Women who took conjugated equine estrogen, a commonly prescribed form of estrogen, had more than twice the risk of developing specific types of benign breast disease as women who took a placebo, according to a randomized ...

Risk of breast cancer and a single-nucleotide polymorphism

Jul 02, 2009

The single-nucleotide polymorphism (SNP) known as 2q35-rs13387042 is associated with increased risk of estrogen receptor (ER) -positive and -negative breast cancer, according to a study published online July 1 in the Journal of ...

No need for gene screens in breast cancer families

Jul 23, 2008

Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a ...

Recommended for you

DNA blood test detects lung cancer mutations

15 hours ago

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

Tumors prefer the easy way out

17 hours ago

Tumor cells become lethal when they spread. Blocking this process can be a powerful way to stop cancer. Historically, scientists thought that tumor cells migrated by brute force, actively pushing through whatever ...

Brain tumors may be new targets of Ebola-like virus

17 hours ago

Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.